FMP
Benitec Biopharma Inc.
BNTC
NASDAQ
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
6.94 USD
0.22 (3.17%)
About
ceo
Dr. Jerel A. Banks M.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://benitec.com
exchange
NASDAQ
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal muscular dystrophy; and BB-103 for the treatment of chronic hepatitis B virus infection. The company was incorporated in 1995 and is headquartered in Hayward, California.
CIK
0001808898
ISIN
US08205P2092
CUSIP
08205P100
Address
3940 Trust Way
Phone
510 780 0819
Country
US
Employee
16
IPO Date
Jun 24, 2014
Summary
CIK
0001808898
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
08205P100
ISIN
US08205P2092
Country
US
Price
6.94
Beta
1.02
Volume Avg.
82.57k
Market Cap
17.99M
Shares
-
52-Week
1.86-9.01
DCF
0.76
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-0.03
P/B
-
Website
https://benitec.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest BNTC News
It looks like there's no news available.
